CA1064038A - COMPOSES DE TYPE 3-(.alpha.-IMINOBENZYL)-4-HYDROXY-6-PHENYL-2(1H)PYRIDONE - Google Patents

COMPOSES DE TYPE 3-(.alpha.-IMINOBENZYL)-4-HYDROXY-6-PHENYL-2(1H)PYRIDONE

Info

Publication number: CA1064038A
Authority: CA; Canada
Prior art keywords: formula; compound; compounds; alkyl; hydrogen
Prior art date: 1975-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA247,763A

Other languages

English (en)

Inventor

Jeffrey Nadelson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-03-14

Filing date

1976-03-12

Publication date

1979-10-09

1976-03-12 Application filed by Sandoz AG filed Critical Sandoz AG

1979-10-09 Application granted granted Critical

1979-10-09 Publication of CA1064038A publication Critical patent/CA1064038A/fr

Status Expired legal-status Critical Current

Links

238000000034 method Methods 0.000 claims abstract description 12
238000004519 manufacturing process Methods 0.000 claims abstract description 4
150000001875 compounds Chemical class 0.000 claims description 37
239000001257 hydrogen Substances 0.000 claims description 11
229910052739 hydrogen Inorganic materials 0.000 claims description 11
239000000460 chlorine Substances 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 7
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 6
229910052801 chlorine Inorganic materials 0.000 claims description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 5
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
239000003960 organic solvent Substances 0.000 claims description 4
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 4
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
125000003545 alkoxy group Chemical group 0.000 claims description 3
239000011737 fluorine Substances 0.000 claims description 3
229910052731 fluorine Inorganic materials 0.000 claims description 3
238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 2
239000000126 substance Substances 0.000 claims description 2
125000004435 hydrogen atom Chemical class [H]* 0.000 claims 4
239000000411 inducer Substances 0.000 abstract description 2
150000002894 organic compounds Chemical class 0.000 abstract 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
239000000203 mixture Substances 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000002253 acid Substances 0.000 description 5
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
150000002431 hydrogen Chemical class 0.000 description 4
230000035484 reaction time Effects 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
239000012267 brine Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000001117 sulphuric acid Substances 0.000 description 3
235000011149 sulphuric acid Nutrition 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000002585 base Substances 0.000 description 2
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
-1 fluorln~ Substances 0.000 description 2
238000005984 hydrogenation reaction Methods 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
235000019341 magnesium sulphate Nutrition 0.000 description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
230000028527 righting reflex Effects 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
YSMODUONRAFBET-UHFFFAOYSA-N 5-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
MVVPIAAVGAWJNQ-DOFZRALJSA-N Arachidonoyl dopamine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCC1=CC=C(O)C(O)=C1 MVVPIAAVGAWJNQ-DOFZRALJSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
206010010904 Convulsion Diseases 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
241000906446 Theraps Species 0.000 description 1
KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
150000001340 alkali metals Chemical group 0.000 description 1
150000001342 alkaline earth metals Chemical group 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
VEQAGSPCZANNDR-UHFFFAOYSA-N azepine-1-sulfonamide Chemical compound NS(=O)(=O)N1C=CC=CC=C1 VEQAGSPCZANNDR-UHFFFAOYSA-N 0.000 description 1
230000006399 behavior Effects 0.000 description 1
159000000007 calcium salts Chemical group 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229940117975 chromium trioxide Drugs 0.000 description 1
WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
230000036461 convulsion Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
239000005457 ice water Substances 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
MAFGERLXTNIVPA-UHFFFAOYSA-N n-methyl-5-phenacyl-3-phenyl-1,2-oxazole-4-carboxamide Chemical compound O1N=C(C=2C=CC=CC=2)C(C(=O)NC)=C1CC(=O)C1=CC=CC=C1 MAFGERLXTNIVPA-UHFFFAOYSA-N 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
229910003446 platinum oxide Inorganic materials 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical group [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
239000012286 potassium permanganate Substances 0.000 description 1
UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000010992 reflux Methods 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000007858 starting material Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
229960002784 thioridazine Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

CA247,763A 1975-03-14 1976-03-12 COMPOSES DE TYPE 3-(.alpha.-IMINOBENZYL)-4-HYDROXY-6-PHENYL-2(1H)PYRIDONE Expired CA1064038A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55841975A	1975-03-14	1975-03-14
US58476475A	1975-06-09	1975-06-09

Publications (1)

Publication Number	Publication Date
CA1064038A true CA1064038A (fr)	1979-10-09

Family

ID=27071738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA247,763A Expired CA1064038A (fr)	1975-03-14	1976-03-12	COMPOSES DE TYPE 3-(.alpha.-IMINOBENZYL)-4-HYDROXY-6-PHENYL-2(1H)PYRIDONE

Country Status (21)

Country	Link
JP (1)	JPS51113877A (fr)
AT (1)	AT358590B (fr)
AU (1)	AU505460B2 (fr)
CA (1)	CA1064038A (fr)
CH (1)	CH601241A5 (fr)
DE (1)	DE2609127A1 (fr)
DK (1)	DK98176A (fr)
ES (1)	ES446035A1 (fr)
FI (1)	FI760572A (fr)
FR (2)	FR2303545A1 (fr)
GB (3)	GB1545575A (fr)
HK (2)	HK46681A (fr)
IE (1)	IE43907B1 (fr)
IL (1)	IL49202A (fr)
MY (2)	MY8200141A (fr)
NL (1)	NL7602494A (fr)
NO (1)	NO760764L (fr)
NZ (1)	NZ180299A (fr)
PT (1)	PT64899B (fr)
SE (1)	SE7602542L (fr)
YU (1)	YU63676A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179566A (en) *	1975-08-06	1979-12-18	Sandoz, Inc.	Substituted hydroxy pyridones
US4238616A (en) *	1977-01-19	1980-12-09	Sandoz, Inc.	3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides
EP1408042A4 (fr)	2001-06-14	2005-02-02	Banyu Pharma Co Ltd	Nouveaux derives d'isoxazolopyridone et leur utilisation
GB0119911D0 (en) *	2001-08-15	2001-10-10	Novartis Ag	Organic Compounds

1976
- 1976-02-26 SE SE7602542A patent/SE7602542L/xx not_active Application Discontinuation
- 1976-03-02 CH CH255876A patent/CH601241A5/xx not_active IP Right Cessation
- 1976-03-05 NO NO760764A patent/NO760764L/no unknown
- 1976-03-05 DE DE19762609127 patent/DE2609127A1/de not_active Withdrawn
- 1976-03-05 DK DK98176*#A patent/DK98176A/da unknown
- 1976-03-05 FI FI760572A patent/FI760572A/fi not_active Application Discontinuation
- 1976-03-09 GB GB9317/76A patent/GB1545575A/en not_active Expired
- 1976-03-09 GB GB38668/78A patent/GB1545577A/en not_active Expired
- 1976-03-09 GB GB38667/78A patent/GB1545576A/en not_active Expired
- 1976-03-10 FR FR7606827A patent/FR2303545A1/fr active Granted
- 1976-03-10 NL NL7602494A patent/NL7602494A/xx not_active Application Discontinuation
- 1976-03-11 YU YU00636/76A patent/YU63676A/xx unknown
- 1976-03-12 IL IL49202A patent/IL49202A/xx unknown
- 1976-03-12 PT PT64899A patent/PT64899B/fr unknown
- 1976-03-12 NZ NZ180299A patent/NZ180299A/xx unknown
- 1976-03-12 JP JP51026228A patent/JPS51113877A/ja active Pending
- 1976-03-12 AT AT181576A patent/AT358590B/de not_active IP Right Cessation
- 1976-03-12 ES ES446035A patent/ES446035A1/es not_active Expired
- 1976-03-12 IE IE528/76A patent/IE43907B1/en unknown
- 1976-03-12 CA CA247,763A patent/CA1064038A/fr not_active Expired
- 1976-03-15 AU AU12012/76A patent/AU505460B2/en not_active Ceased
- 1976-11-30 FR FR7636022A patent/FR2371435A1/fr active Granted
1981
- 1981-09-17 HK HK466/81A patent/HK46681A/xx unknown
- 1981-09-17 HK HK465/81A patent/HK46581A/xx unknown
1982
- 1982-12-30 MY MY141/82A patent/MY8200141A/xx unknown
- 1982-12-30 MY MY142/82A patent/MY8200142A/xx unknown

Also Published As

Publication number	Publication date
FR2303545A1 (fr)	1976-10-08
MY8200141A (en)	1982-12-31
NZ180299A (en)	1978-07-28
YU63676A (en)	1982-02-28
NO760764L (fr)	1976-09-15
DK98176A (da)	1976-09-15
AU505460B2 (en)	1979-11-22
IE43907L (en)	1976-09-14
AT358590B (de)	1980-09-25
PT64899A (fr)	1976-04-01
AU1201276A (en)	1977-09-22
PT64899B (fr)	1977-08-18
GB1545576A (en)	1979-05-10
ATA181576A (de)	1980-02-15
ES446035A1 (es)	1977-09-16
SE7602542L (sv)	1976-09-15
IE43907B1 (en)	1981-07-01
HK46581A (en)	1981-09-25
CH601241A5 (fr)	1978-06-30
FR2371435A1 (fr)	1978-06-16
MY8200142A (en)	1982-12-31
NL7602494A (nl)	1976-09-16
FI760572A (fr)	1976-09-15
JPS51113877A (en)	1976-10-07
DE2609127A1 (de)	1976-09-23
IL49202A (en)	1979-09-30
GB1545577A (en)	1979-05-10
HK46681A (en)	1981-09-25
GB1545575A (en)	1979-05-10
IL49202A0 (en)	1976-05-31
FR2303545B1 (fr)	1982-03-19
FR2371435B1 (fr)	1980-03-07

Publication	Publication Date	Title
US4083980A (en)	1978-04-11	Derivatives of quinazolone
CA1210770A (fr)	1986-09-02	Antagonistes des leukotrienes
WO2003014107A1 (fr)	2003-02-20	Procede de preparation de derives heterocycliques de pentalene
CA1273929A (fr)	1990-09-11	N-(piperidinylaklyl) carboxamides
EP0925291B1 (fr)	2005-11-30	Ligands spirocycliques d'un sous-type du recepteur de la dopamine
CA1064038A (fr)	1979-10-09	COMPOSES DE TYPE 3-(.alpha.-IMINOBENZYL)-4-HYDROXY-6-PHENYL-2(1H)PYRIDONE
CA1235703A (fr)	1988-04-26	Derives de substitution en 6 de 6h-dibenzo/b.d/pyranne; methode de preparation
SU474981A3 (ru)	1975-06-25	Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей
Bauer et al.	1976	Synthesis of spiro [isobenzofuran-1 (3H), 4'-piperidines] as potential central nervous system agents. 1
EP0156331B1 (fr)	1989-05-31	Dérivés de benzofuranne, procédé pour leur préparation et agents antihypertensifs les contenant
IE42486B1 (en)	1980-08-13	Tetralone and indanone derivatives and process for their preparation
CA1203801A (fr)	1986-04-29	Derives de piperazines, leur preparation et produits pharmaceutiques qui les renferment
US3308121A (en)	1967-03-07	3-morpholinones, thiones and 5, 6 oxazines
Kawashima et al.	1986	Structure-activity studies of 4, 6-disubstituted 2-(morpholinocarbonyl) furo [3, 2-b] indole derivatives with analgesic and antiinflammatory activities
PL143370B1 (en)	1988-02-29	Method of obtaining derivatives of 6-monobromopenicillanic acid
CA1156235A (fr)	1983-11-01	1-(8-quinolyl)-2-pyrrolidinone
CA1090344A (fr)	1980-11-25	3-(tetrazol-5-y1)-1-azaxanthones
US3818090A (en)	1974-06-18	Novel quinolines in the treatment of pain and inflammation
SU957766A3 (ru)	1982-09-07	Способ получени замещенных 2-циклопропилхромонов или их солей
CA1064935A (fr)	1979-10-23	Production de 3-iminoalkyl-1(1h)-pyridines
US4179566A (en)	1979-12-18	Substituted hydroxy pyridones
US4260612A (en)	1981-04-07	Antiallergic nitrogen bridge-head compounds
US4128549A (en)	1978-12-05	Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones
CA1068716A (fr)	1979-12-25	Amides cycliques methylees
CA2030112A1 (fr)	1991-05-25	Compose de xanthine, methode de preparation et composition pharmaceutique contenant ledit compose